Consideration of acamprosate for treatment of amyotrophic lateral sclerosis

Medical Hypotheses

Volumn 69, Issue 4, 2007, Pages 836-837

  Kast, Richard E ^a   Altschuler, Eric Lewin ^b,c  

^a UNIVERSITY OF VERMONT   (United States)

^b University of Medicine and Dentistry of New Jersey   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACAMPROSATE; AMPA RECEPTOR; CADAVERINE; CALCIUM; COPPER ZINC SUPEROXIDE DISMUTASE; POLYAMINE; PUTRESCINE; SPERMIDINE; SPERMINE;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CELL DEATH; DRUG MECHANISM; MOTONEURON; PRIORITY JOURNAL; RNA EDITING;

ANIMALS; CALCIUM; DISEASE MODELS, ANIMAL; HUMANS; MICE; MOTOR NEURON DISEASE; MOTOR NEURONS; TAURINE;

EID: 34547840269     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2007.01.072     Document Type: Article

References (6)

1. Meininger V. Clinical trials in ALS: what did we learn from recent trials in humans?. Neurodegener Dis 2 (2005) 208-214
2. Kawahara Y., Ito K., Sun H., Aizawa H., Kanazawa I., and Kwak S. Glutamate receptors: RNA editing and death of motor neurons. Nature 427 (2004) 801
3. Soyka M., and Roesner S. New pharmacological approaches for the treatment of alcoholism. Expert Opin Pharmacother 7 (2006) 2341-2353
4. Naassila M., Hammoumi S., Legrand E., Durbin P., and Daoust M. Mechanism of action of acamprosate. Part I. Characterization of spermidine-sensitive acamprosate binding site in rat brain. Alcohol Clin Exp Res 22 (1998) 802-809
5. Van Damme P., Van den Bosch L., Van Houtte E., Callewaert G., and Robberecht W. GluR2-dependent properties of AMPA receptors determine the selective vulnerability of motor neurons to excitotoxicity. J Neurophysiol 88 (2002) 1279-1287
6. Kawahara Y., Sun H., Ito K., Hideyama T., Aoki M., Sobue G., et al. Under editing of GluR2 mRNA, a neuronal death inducing molecular change in sporadic ALS, does not occur in motor neurons in ALS1 or SBMA. Neurosci Res 54 (2006) 11-14